Noninvasive low-level laser therapy for thrombocytopenia.

What the authors concluded

This safe, drug-free, donor-independent modality represents a paradigm shift in the prophylaxis and treatment of thrombocytopenia. " "We demonstrate here that noninvasive whole-body LLL illumination increases platelet generation and completely cures or greatly ameliorates thrombocytopenia caused by γ-irradiation (IR), ITP (induced by anti-CD41 antibody), or chemotherapy in mice." Comment: Figur

Devices that emit this wavelength

Matched on wavelength within 15nm, since LED bins vary by roughly that much and a tighter match would be false precision. Where we have an irradiance figure, the session length is the time needed to reach this study's dose of 30 J/cm² at that intensity.

Matching a wavelength is not the same as reproducing a trial. Session times assume the device's published irradiance is accurate at the distance it was measured, which on brand-claim figures is often optimistic. Where a device publishes both a peak and an average we use the average, and where it publishes a falloff curve we use the lowest figure, so these times run long rather than short. Clinical protocols also control for spot size, contact and skin type in ways a home device cannot.